Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Diarrhea 3Prostatic Neoplasms 2Neoplasms 2Breast Neoplasms 2Vipoma 1Somatostatinoma 1Serotonin Syndrome 1Recurrence 1Rectal Neoplasms 1Pheochromocytoma 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Lymphocele 1Intestinal Obstruction 1Insulinoma 1Head and Neck Neoplasms 1Glucagonoma 1Gastro-enteropancreatic neuroendocrine tumor 1Gastrinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Medullary 1Carcinoma, Islet Cell 1Adenoma, Islet Cell 1Adenoma 1Acromegaly 1

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Octreotide × Clear all
NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated
4 enrolled
Breast

Breast Neoplasms, Lymphocele

NCT02294786 2019-07-15

Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer

Novartis

Phase 2 Terminated
62 enrolled 25 charts
Breast

Breast Neoplasms, Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡